---
Aliases:
---
# Second line treatment for dyslipidaemia by acting as a PPAR antagonist to increase LPL activity
## Includes:
### Fenofibrate (Lipidil)
## Indications: 
### Isolated elevated TAGs -> esp. those that are overweight with isolated [[Hypertriglyceridaemia]] with low HDL
### Second line therapy for elevated LDL
## Side effects:
### Skin rashes
### hepatotoxicity, myositis
### [[Cholelithiasis]]
# Countra indications
## Be careful when using with a statin -> induce [[Rhabdomyolysis]]
## Established liver disease or severe kidney disease (eGFR < 10)
## Established [[Cholelithiasis]]
# Administration 
# Monitering 


---
#drug 